FindTrial
Sign In

Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis

Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis - Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005797
Enrollment
100
Registered
2011-06-20
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

neutralizing antibody assay

Sponsors

Department of Neurology, Tohoku University School of Medicine
Lead Sponsor
Juntendo University School of Medicine Tokyo Women&#39
Collaborator
s Medical University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: multiple sclerosis treating with interferon-beta

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Analysis of frequency of interferon-beta neutralizing antibody in Japanese patients with multiple sclerosis treated by interferon-beta—

Countries

Japan

Contacts

Public ContactIchiro Nakashima

Tohoku Univesity School of Medicine Department of Neurology

ichiro.nakashima@gmail.com022-717-7188

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026